Insight into early-phase trials for lung cancer in the United States.
CONCLUSIONS: These data suggest that a significantly higher percentage of phase 1 trials for lung cancer were conducted in the US than in China. Early-phase oncology trials with robust preclinical data had a higher chance of being approved by the Investigational Drug Branch at the CTEP/NCI. Given the importance of early-phase oncology trials in developing innovative cancer medicines, such studies should be highly encouraged and strategically funded in China.
PMID: 26162603 [PubMed - in process]
Source: Chinese Journal of Cancer - Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Lung Cancer | Study | Texas University | University of Wisconsin | USA Health